• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂(serpin)裂解区域中高度保守的色氨酸突变改变了纤溶酶原激活物抑制剂-1的抑制机制。

Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.

作者信息

Blouse Grant E, Perron Michel J, Kvassman Jan-Olov, Yunus Saadia, Thompson Jannah H, Betts Russell L, Lutter Leonard C, Shore Joseph D

机构信息

Department of Pathology, Division of Biochemical Research, Henry Ford Health Sciences Center, Detroit, Michigan 48202-2689, USA.

出版信息

Biochemistry. 2003 Oct 28;42(42):12260-72. doi: 10.1021/bi034737n.

DOI:10.1021/bi034737n
PMID:14567688
Abstract

We have demonstrated that interactions within the conserved serpin breach region play a direct role in the critical step of the serpin reaction in which the acyl-enzyme intermediate must first be exposed to hydrolyzing water and aqueous deacylation. Substitution of the breach tryptophan in PAI-1 (Trp175), a residue found in virtually all known serpins, with phenylalanine altered the kinetics of the reaction mechanism and impeded the ability of PAI-1 to spontaneously become latent without compromising the inherent rate of cleaved loop insertion or partitioning between the final inhibited serpin-proteinase complex and hydrolyzed serpin. Kinetic dissection of the PAI-1 inhibitory mechanism using multiple target proteinases made possible the identification of a single rate-limiting intermediate step coupled to the molecular interactions within the breach region. This step involves the initial insertion of the proximal reactive center loop hinge residue(s) into beta-sheet A and facilitates translocation of the distal P'-side of the cleaved reactive center loop from the substrate cleft of the proteinase. Substitution of the tryptophan residue raised the kinetic barrier restricting the initial loop insertion event, significantly retarding the rate-limiting step in tPA reactions in which strong exosite interactions must be overcome for the reaction to proceed.

摘要

我们已经证明,在保守的丝氨酸蛋白酶抑制剂(serpin)裂隙区域内的相互作用,在丝氨酸蛋白酶抑制剂反应的关键步骤中发挥直接作用,在该步骤中,酰基酶中间体必须首先暴露于水解水和水性脱酰基反应中。将几乎所有已知丝氨酸蛋白酶抑制剂中都存在的PAI-1(Trp175)中的裂隙色氨酸替换为苯丙氨酸,改变了反应机制的动力学,并阻碍了PAI-1自发潜伏的能力,同时不影响裂解环插入的固有速率或最终抑制性丝氨酸蛋白酶抑制剂 - 蛋白酶复合物与水解丝氨酸蛋白酶抑制剂之间的分配。使用多种靶蛋白酶对PAI-1抑制机制进行动力学剖析,使得能够识别与裂隙区域内分子相互作用相关的单个限速中间步骤。该步骤涉及近端反应中心环铰链残基最初插入β-折叠A中,并促进裂解的反应中心环的远端P'侧从蛋白酶的底物裂隙中移位。色氨酸残基的替换提高了限制初始环插入事件的动力学障碍,显著延迟了tPA反应中的限速步骤,在该反应中必须克服强烈的外部位点相互作用才能使反应进行。

相似文献

1
Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.丝氨酸蛋白酶抑制剂(serpin)裂解区域中高度保守的色氨酸突变改变了纤溶酶原激活物抑制剂-1的抑制机制。
Biochemistry. 2003 Oct 28;42(42):12260-72. doi: 10.1021/bi034737n.
2
Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.丝氨酸蛋白酶抑制剂(Serpins)的抑制机制:环插入促使纤溶酶原激活物抑制剂-1对纤溶酶原激活物进行酰化作用。
Biochemistry. 1998 Nov 3;37(44):15491-502. doi: 10.1021/bi9814787.
3
Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1与组织纤溶酶原激活物及胰蛋白酶反应中米氏复合物的解离、酰化及构象变化步骤
Biochemistry. 2001 Oct 2;40(39):11742-56. doi: 10.1021/bi0107290.
4
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.纤溶酶原激活物抑制剂-1的底物行为与反应位点环插入缺失无关。
Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d.
5
Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.纤溶酶原激活物抑制剂-1与其靶蛋白酶之间复合物形成的合理设计。
J Struct Biol. 1997 Apr;118(3):236-42. doi: 10.1006/jsbi.1997.3860.
6
Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.卵清蛋白中的丝氨酸蛋白酶抑制剂构象变化。通过铰链区突变增强反应中心环插入。
Biochemistry. 1997 May 6;36(18):5432-40. doi: 10.1021/bi9702142.
7
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.组织型纤溶酶原激活物的可变区-1通过促进催化作用赋予纤溶酶原激活物抑制剂-1对凝血酶的特异性:由异源蛋白质表面环解除动力学阻滞。
J Mol Biol. 1999 Oct 29;293(3):613-27. doi: 10.1006/jmbi.1999.3178.
8
The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.纤溶酶原激活物抑制剂-1的外部位点残基对蛋白酶抑制作用的贡献。
J Biol Chem. 2004 Jan 30;279(5):3643-50. doi: 10.1074/jbc.M310601200. Epub 2003 Oct 31.
9
A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.纤溶酶原激活物抑制剂-1抑制机制中的协同结构转变。
Biochemistry. 2002 Oct 8;41(40):11997-2009. doi: 10.1021/bi025967p.
10
19F NMR studies of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的19F核磁共振研究。
Biochemistry. 2004 Feb 17;43(6):1507-19. doi: 10.1021/bi035618a.

引用本文的文献

1
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.心血管疾病中靶向纤溶酶原激活物抑制剂-1:纤溶酶原激活物抑制剂-1功能及抑制作用的结构见解
Front Cardiovasc Med. 2020 Dec 22;7:622473. doi: 10.3389/fcvm.2020.622473. eCollection 2020.
2
Identification of a PAI-1-binding site within an intrinsically disordered region of vitronectin.鉴定纤连蛋白无规则卷曲结构域内的一个纤溶酶原激活物抑制剂-1 结合位点。
Protein Sci. 2020 Feb;29(2):494-508. doi: 10.1002/pro.3770. Epub 2019 Nov 20.
3
Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors.
生化和结构分析表明,纤溶酶原激活物与其同源蛋白底物和抑制剂是共同进化的。
J Biol Chem. 2019 Mar 8;294(10):3794-3805. doi: 10.1074/jbc.RA118.005419. Epub 2019 Jan 16.
4
Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.抑制性丝氨酸蛋白酶抑制剂。对其折叠、聚合、调节和清除的新见解。
Biochem J. 2016 Aug 1;473(15):2273-93. doi: 10.1042/BCJ20160014.
5
Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1.纤溶酶原激活物抑制剂-1对组织型纤溶酶原激活物特异性抑制的结构基础
Data Brief. 2016 Jan 6;6:550-5. doi: 10.1016/j.dib.2015.12.050. eCollection 2016 Mar.
6
The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.纤溶酶原激活物抑制剂-1(PAI-1)上与低密度脂蛋白受体相关蛋白(LRP1)结合的高亲和力位点由四个碱性残基组成。
J Biol Chem. 2016 Jan 8;291(2):800-12. doi: 10.1074/jbc.M115.688820. Epub 2015 Nov 10.
7
Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.活性中心环构象和动力学变化揭示了纤溶酶原激活物抑制剂-1(PAI-1)与纤溶酶原激活物及玻连蛋白形成的不同结合复合物。
Protein Sci. 2016 Feb;25(2):499-510. doi: 10.1002/pro.2841. Epub 2015 Dec 2.
8
Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.沿着反应中心环的单个荧光探针揭示了纤溶酶原激活物抑制剂-1潜伏转变过程中的位点特异性变化。
Protein Sci. 2016 Feb;25(2):487-98. doi: 10.1002/pro.2839. Epub 2015 Nov 25.
9
Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.硬骨鱼类尿激酶型纤溶酶原激活物样蛋白酶缺乏真正的受体结合表皮生长因子样结构域。
J Biol Chem. 2012 Aug 10;287(33):27526-36. doi: 10.1074/jbc.M112.369207. Epub 2012 Jun 25.
10
Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability.纤溶酶原激活物抑制剂-1 处于活性构象及具有正常热力学稳定性的晶体结构。
J Biol Chem. 2011 Aug 26;286(34):29709-17. doi: 10.1074/jbc.M111.236554. Epub 2011 Jun 21.